After 3 platforms receive fast track approval with potential success for Ager-Cell looking very promising, the SP is still in reverse gear at all time low at 32C
Who should we blame now, economic condition, S&P rebalance, the IMU management (trustworthy or untrustworthy), declining short position, delay in data release, high remuneration of management (highly paid?, the lifestyle holding) , PH who is always looking to sell when price appreciation starts.
Until we cross the line, we all are in race, some tumble, some will have cramp, some may be disqualified but IMU eventual goal is to treat patience with failed treatment who are end of life. The most fit to race platforms (3 now) running towards the final line, needs to reveal data that substantiate a Complete Response (about 70%) and all nitty-gritty will rest.
Patience and time can only confirm, if we cross the line. Believe in Science
IMU Price at posting:
3.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)